nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ALB—liver cancer	0.464	1	CbGaD
Alfentanil—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.107	0.25	CbGbCtD
Alfentanil—CYP3A7—Sorafenib—liver cancer	0.107	0.25	CbGbCtD
Alfentanil—CYP3A5—Sorafenib—liver cancer	0.08	0.187	CbGbCtD
Alfentanil—ABCB1—Sorafenib—liver cancer	0.052	0.122	CbGbCtD
Alfentanil—ABCB1—Doxorubicin—liver cancer	0.0316	0.074	CbGbCtD
Alfentanil—CYP3A4—Sorafenib—liver cancer	0.0312	0.073	CbGbCtD
Alfentanil—CYP3A4—Doxorubicin—liver cancer	0.0189	0.0443	CbGbCtD
Alfentanil—ORM1—bile—liver cancer	0.00652	0.484	CbGeAlD
Alfentanil—ORM1—gall bladder—liver cancer	0.00181	0.134	CbGeAlD
Alfentanil—ALB—gall bladder—liver cancer	0.00159	0.118	CbGeAlD
Alfentanil—Blood pressure increased—Sorafenib—liver cancer	0.00134	0.037	CcSEcCtD
Alfentanil—CYP3A7—liver—liver cancer	0.000839	0.0622	CbGeAlD
Alfentanil—CYP3A7-CYP3A51P—liver—liver cancer	0.000713	0.0529	CbGeAlD
Alfentanil—Epistaxis—Sorafenib—liver cancer	0.000705	0.0195	CcSEcCtD
Alfentanil—Dermatitis atopic—Epirubicin—liver cancer	0.000667	0.0184	CcSEcCtD
Alfentanil—Connective tissue disorder—Sorafenib—liver cancer	0.00066	0.0182	CcSEcCtD
Alfentanil—Cardiac disorder—Sorafenib—liver cancer	0.000623	0.0172	CcSEcCtD
Alfentanil—Dermatitis atopic—Doxorubicin—liver cancer	0.000618	0.0171	CcSEcCtD
Alfentanil—Angiopathy—Sorafenib—liver cancer	0.000609	0.0168	CcSEcCtD
Alfentanil—Immune system disorder—Sorafenib—liver cancer	0.000606	0.0168	CcSEcCtD
Alfentanil—Injection site pain—Epirubicin—liver cancer	0.000605	0.0167	CcSEcCtD
Alfentanil—Mediastinal disorder—Sorafenib—liver cancer	0.000605	0.0167	CcSEcCtD
Alfentanil—Arrhythmia—Sorafenib—liver cancer	0.0006	0.0166	CcSEcCtD
Alfentanil—Mental disorder—Sorafenib—liver cancer	0.000588	0.0163	CcSEcCtD
Alfentanil—Erythema—Sorafenib—liver cancer	0.000584	0.0162	CcSEcCtD
Alfentanil—Injection site pain—Doxorubicin—liver cancer	0.00056	0.0155	CcSEcCtD
Alfentanil—ORM1—liver—liver cancer	0.000531	0.0394	CbGeAlD
Alfentanil—Dyskinesia—Epirubicin—liver cancer	0.000526	0.0145	CcSEcCtD
Alfentanil—Loss of consciousness—Sorafenib—liver cancer	0.000514	0.0142	CcSEcCtD
Alfentanil—Cough—Sorafenib—liver cancer	0.00051	0.0141	CcSEcCtD
Alfentanil—Hypertension—Sorafenib—liver cancer	0.000504	0.0139	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000494	0.0137	CcSEcCtD
Alfentanil—Hiccups—Epirubicin—liver cancer	0.000494	0.0137	CcSEcCtD
Alfentanil—Dyskinesia—Doxorubicin—liver cancer	0.000486	0.0134	CcSEcCtD
Alfentanil—Anaphylactic shock—Sorafenib—liver cancer	0.000477	0.0132	CcSEcCtD
Alfentanil—Nervous system disorder—Sorafenib—liver cancer	0.000468	0.0129	CcSEcCtD
Alfentanil—ALB—liver—liver cancer	0.000466	0.0345	CbGeAlD
Alfentanil—Skin disorder—Sorafenib—liver cancer	0.000463	0.0128	CcSEcCtD
Alfentanil—Hiccups—Doxorubicin—liver cancer	0.000457	0.0126	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Sorafenib—liver cancer	0.000412	0.0114	CcSEcCtD
Alfentanil—Fatigue—Sorafenib—liver cancer	0.000411	0.0114	CcSEcCtD
Alfentanil—Pain—Sorafenib—liver cancer	0.000408	0.0113	CcSEcCtD
Alfentanil—Urticaria—Sorafenib—liver cancer	0.000379	0.0105	CcSEcCtD
Alfentanil—Body temperature increased—Sorafenib—liver cancer	0.000377	0.0104	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Epirubicin—liver cancer	0.00037	0.0102	CcSEcCtD
Alfentanil—Hypersensitivity—Sorafenib—liver cancer	0.000351	0.00971	CcSEcCtD
Alfentanil—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000343	0.00948	CcSEcCtD
Alfentanil—Asthenia—Sorafenib—liver cancer	0.000342	0.00946	CcSEcCtD
Alfentanil—Cardiac arrest—Epirubicin—liver cancer	0.000341	0.00943	CcSEcCtD
Alfentanil—ABCB1—embryo—liver cancer	0.000339	0.0251	CbGeAlD
Alfentanil—Pruritus—Sorafenib—liver cancer	0.000337	0.00933	CcSEcCtD
Alfentanil—Cardiac arrest—Doxorubicin—liver cancer	0.000315	0.00872	CcSEcCtD
Alfentanil—Dizziness—Sorafenib—liver cancer	0.000315	0.00872	CcSEcCtD
Alfentanil—Vomiting—Sorafenib—liver cancer	0.000303	0.00838	CcSEcCtD
Alfentanil—Rash—Sorafenib—liver cancer	0.000301	0.00831	CcSEcCtD
Alfentanil—Dermatitis—Sorafenib—liver cancer	0.0003	0.0083	CcSEcCtD
Alfentanil—Headache—Sorafenib—liver cancer	0.000299	0.00826	CcSEcCtD
Alfentanil—CYP3A5—liver—liver cancer	0.000295	0.0219	CbGeAlD
Alfentanil—Nausea—Sorafenib—liver cancer	0.000283	0.00783	CcSEcCtD
Alfentanil—Drowsiness—Epirubicin—liver cancer	0.000276	0.00764	CcSEcCtD
Alfentanil—Epistaxis—Epirubicin—liver cancer	0.000261	0.00721	CcSEcCtD
Alfentanil—Drowsiness—Doxorubicin—liver cancer	0.000256	0.00707	CcSEcCtD
Alfentanil—Bradycardia—Epirubicin—liver cancer	0.000253	0.00698	CcSEcCtD
Alfentanil—Connective tissue disorder—Epirubicin—liver cancer	0.000244	0.00674	CcSEcCtD
Alfentanil—Epistaxis—Doxorubicin—liver cancer	0.000241	0.00667	CcSEcCtD
Alfentanil—Visual impairment—Epirubicin—liver cancer	0.000239	0.00661	CcSEcCtD
Alfentanil—Bradycardia—Doxorubicin—liver cancer	0.000234	0.00646	CcSEcCtD
Alfentanil—Eye disorder—Epirubicin—liver cancer	0.000232	0.00641	CcSEcCtD
Alfentanil—Cardiac disorder—Epirubicin—liver cancer	0.00023	0.00636	CcSEcCtD
Alfentanil—Connective tissue disorder—Doxorubicin—liver cancer	0.000226	0.00624	CcSEcCtD
Alfentanil—Angiopathy—Epirubicin—liver cancer	0.000225	0.00622	CcSEcCtD
Alfentanil—Immune system disorder—Epirubicin—liver cancer	0.000224	0.00619	CcSEcCtD
Alfentanil—Mediastinal disorder—Epirubicin—liver cancer	0.000224	0.00618	CcSEcCtD
Alfentanil—Chills—Epirubicin—liver cancer	0.000223	0.00615	CcSEcCtD
Alfentanil—CYP3A4—liver—liver cancer	0.000222	0.0164	CbGeAlD
Alfentanil—Arrhythmia—Epirubicin—liver cancer	0.000222	0.00613	CcSEcCtD
Alfentanil—Visual impairment—Doxorubicin—liver cancer	0.000221	0.00611	CcSEcCtD
Alfentanil—Mental disorder—Epirubicin—liver cancer	0.000217	0.00601	CcSEcCtD
Alfentanil—Erythema—Epirubicin—liver cancer	0.000216	0.00597	CcSEcCtD
Alfentanil—Eye disorder—Doxorubicin—liver cancer	0.000215	0.00593	CcSEcCtD
Alfentanil—Cardiac disorder—Doxorubicin—liver cancer	0.000213	0.00589	CcSEcCtD
Alfentanil—Angiopathy—Doxorubicin—liver cancer	0.000208	0.00576	CcSEcCtD
Alfentanil—Immune system disorder—Doxorubicin—liver cancer	0.000207	0.00573	CcSEcCtD
Alfentanil—Mediastinal disorder—Doxorubicin—liver cancer	0.000207	0.00572	CcSEcCtD
Alfentanil—Chills—Doxorubicin—liver cancer	0.000206	0.00569	CcSEcCtD
Alfentanil—Arrhythmia—Doxorubicin—liver cancer	0.000205	0.00567	CcSEcCtD
Alfentanil—Vision blurred—Epirubicin—liver cancer	0.000204	0.00563	CcSEcCtD
Alfentanil—Mental disorder—Doxorubicin—liver cancer	0.000201	0.00556	CcSEcCtD
Alfentanil—Erythema—Doxorubicin—liver cancer	0.0002	0.00552	CcSEcCtD
Alfentanil—Agitation—Epirubicin—liver cancer	0.000198	0.00549	CcSEcCtD
Alfentanil—Loss of consciousness—Epirubicin—liver cancer	0.00019	0.00525	CcSEcCtD
Alfentanil—Cough—Epirubicin—liver cancer	0.000188	0.00521	CcSEcCtD
Alfentanil—Vision blurred—Doxorubicin—liver cancer	0.000188	0.00521	CcSEcCtD
Alfentanil—Convulsion—Epirubicin—liver cancer	0.000187	0.00517	CcSEcCtD
Alfentanil—Hypertension—Epirubicin—liver cancer	0.000186	0.00515	CcSEcCtD
Alfentanil—Agitation—Doxorubicin—liver cancer	0.000184	0.00508	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000183	0.00505	CcSEcCtD
Alfentanil—Confusional state—Epirubicin—liver cancer	0.000178	0.00491	CcSEcCtD
Alfentanil—Anaphylactic shock—Epirubicin—liver cancer	0.000176	0.00487	CcSEcCtD
Alfentanil—Loss of consciousness—Doxorubicin—liver cancer	0.000176	0.00485	CcSEcCtD
Alfentanil—Cough—Doxorubicin—liver cancer	0.000174	0.00482	CcSEcCtD
Alfentanil—Convulsion—Doxorubicin—liver cancer	0.000173	0.00479	CcSEcCtD
Alfentanil—Nervous system disorder—Epirubicin—liver cancer	0.000173	0.00478	CcSEcCtD
Alfentanil—Hypertension—Doxorubicin—liver cancer	0.000173	0.00477	CcSEcCtD
Alfentanil—Tachycardia—Epirubicin—liver cancer	0.000172	0.00475	CcSEcCtD
Alfentanil—Skin disorder—Epirubicin—liver cancer	0.000171	0.00473	CcSEcCtD
Alfentanil—Hyperhidrosis—Epirubicin—liver cancer	0.00017	0.00471	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000169	0.00467	CcSEcCtD
Alfentanil—Hypotension—Epirubicin—liver cancer	0.000165	0.00455	CcSEcCtD
Alfentanil—Confusional state—Doxorubicin—liver cancer	0.000164	0.00455	CcSEcCtD
Alfentanil—Anaphylactic shock—Doxorubicin—liver cancer	0.000163	0.00451	CcSEcCtD
Alfentanil—Nervous system disorder—Doxorubicin—liver cancer	0.00016	0.00442	CcSEcCtD
Alfentanil—Tachycardia—Doxorubicin—liver cancer	0.000159	0.0044	CcSEcCtD
Alfentanil—Skin disorder—Doxorubicin—liver cancer	0.000158	0.00438	CcSEcCtD
Alfentanil—Hyperhidrosis—Doxorubicin—liver cancer	0.000158	0.00436	CcSEcCtD
Alfentanil—ABCB1—liver—liver cancer	0.000157	0.0116	CbGeAlD
Alfentanil—Somnolence—Epirubicin—liver cancer	0.000157	0.00433	CcSEcCtD
Alfentanil—Hypotension—Doxorubicin—liver cancer	0.000152	0.00421	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Epirubicin—liver cancer	0.000152	0.00421	CcSEcCtD
Alfentanil—Fatigue—Epirubicin—liver cancer	0.000152	0.0042	CcSEcCtD
Alfentanil—Pain—Epirubicin—liver cancer	0.000151	0.00417	CcSEcCtD
Alfentanil—Feeling abnormal—Epirubicin—liver cancer	0.000145	0.00401	CcSEcCtD
Alfentanil—Somnolence—Doxorubicin—liver cancer	0.000145	0.00401	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000141	0.00389	CcSEcCtD
Alfentanil—Fatigue—Doxorubicin—liver cancer	0.000141	0.00389	CcSEcCtD
Alfentanil—Urticaria—Epirubicin—liver cancer	0.00014	0.00387	CcSEcCtD
Alfentanil—Pain—Doxorubicin—liver cancer	0.000139	0.00385	CcSEcCtD
Alfentanil—Body temperature increased—Epirubicin—liver cancer	0.000139	0.00385	CcSEcCtD
Alfentanil—Feeling abnormal—Doxorubicin—liver cancer	0.000134	0.00371	CcSEcCtD
Alfentanil—Hypersensitivity—Epirubicin—liver cancer	0.00013	0.00359	CcSEcCtD
Alfentanil—Urticaria—Doxorubicin—liver cancer	0.00013	0.00358	CcSEcCtD
Alfentanil—Body temperature increased—Doxorubicin—liver cancer	0.000129	0.00356	CcSEcCtD
Alfentanil—Asthenia—Epirubicin—liver cancer	0.000126	0.0035	CcSEcCtD
Alfentanil—Pruritus—Epirubicin—liver cancer	0.000125	0.00345	CcSEcCtD
Alfentanil—Hypersensitivity—Doxorubicin—liver cancer	0.00012	0.00332	CcSEcCtD
Alfentanil—Asthenia—Doxorubicin—liver cancer	0.000117	0.00323	CcSEcCtD
Alfentanil—Dizziness—Epirubicin—liver cancer	0.000117	0.00322	CcSEcCtD
Alfentanil—Pruritus—Doxorubicin—liver cancer	0.000115	0.00319	CcSEcCtD
Alfentanil—Vomiting—Epirubicin—liver cancer	0.000112	0.0031	CcSEcCtD
Alfentanil—Rash—Epirubicin—liver cancer	0.000111	0.00307	CcSEcCtD
Alfentanil—Dermatitis—Epirubicin—liver cancer	0.000111	0.00307	CcSEcCtD
Alfentanil—Headache—Epirubicin—liver cancer	0.00011	0.00305	CcSEcCtD
Alfentanil—Dizziness—Doxorubicin—liver cancer	0.000108	0.00298	CcSEcCtD
Alfentanil—Nausea—Epirubicin—liver cancer	0.000105	0.00289	CcSEcCtD
Alfentanil—Vomiting—Doxorubicin—liver cancer	0.000104	0.00287	CcSEcCtD
Alfentanil—Rash—Doxorubicin—liver cancer	0.000103	0.00284	CcSEcCtD
Alfentanil—Dermatitis—Doxorubicin—liver cancer	0.000103	0.00284	CcSEcCtD
Alfentanil—Headache—Doxorubicin—liver cancer	0.000102	0.00282	CcSEcCtD
Alfentanil—Nausea—Doxorubicin—liver cancer	9.69e-05	0.00268	CcSEcCtD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	3.04e-05	0.000514	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CPT1B—liver cancer	3.04e-05	0.000513	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GLUL—liver cancer	3.04e-05	0.000513	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	3.02e-05	0.000511	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—HGF—liver cancer	2.98e-05	0.000504	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	2.98e-05	0.000504	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTA2—liver cancer	2.98e-05	0.000503	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—CSF2—liver cancer	2.95e-05	0.000498	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NR1H4—liver cancer	2.93e-05	0.000495	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	2.9e-05	0.00049	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ADAM17—liver cancer	2.9e-05	0.000489	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	2.9e-05	0.000489	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTA3—liver cancer	2.88e-05	0.000486	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTA1—liver cancer	2.88e-05	0.000486	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	2.87e-05	0.000485	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—NAT2—liver cancer	2.84e-05	0.00048	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	2.81e-05	0.000474	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PSMA4—liver cancer	2.8e-05	0.000473	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PSMD10—liver cancer	2.8e-05	0.000473	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	2.79e-05	0.000472	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	2.77e-05	0.000468	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	2.74e-05	0.000463	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—F2—liver cancer	2.73e-05	0.000461	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GOT2—liver cancer	2.73e-05	0.00046	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALDOB—liver cancer	2.73e-05	0.00046	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PSMA4—liver cancer	2.72e-05	0.00046	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PSMD10—liver cancer	2.72e-05	0.00046	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—UGDH—liver cancer	2.71e-05	0.000457	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GLUL—liver cancer	2.66e-05	0.00045	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CPT1B—liver cancer	2.66e-05	0.00045	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTA4—liver cancer	2.63e-05	0.000445	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CG—liver cancer	2.61e-05	0.000442	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CRABP1—liver cancer	2.6e-05	0.000439	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.57e-05	0.000435	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	2.57e-05	0.000434	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTA2—liver cancer	2.57e-05	0.000434	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NR1H4—liver cancer	2.57e-05	0.000433	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP2E1—liver cancer	2.56e-05	0.000433	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—EPT1—liver cancer	2.54e-05	0.00043	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	2.53e-05	0.000427	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTA3—liver cancer	2.52e-05	0.000426	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—F2—liver cancer	2.48e-05	0.000419	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTA1—liver cancer	2.48e-05	0.000418	CbGpPWpGaD
Alfentanil—ALB—Metabolism—NAT2—liver cancer	2.45e-05	0.000414	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	2.43e-05	0.00041	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—TAT—liver cancer	2.41e-05	0.000407	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYCS—liver cancer	2.4e-05	0.000405	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MAPK14—liver cancer	2.39e-05	0.000403	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CG—liver cancer	2.37e-05	0.000401	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	2.36e-05	0.000398	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.35e-05	0.000398	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GOT1—liver cancer	2.35e-05	0.000397	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GGT1—liver cancer	2.35e-05	0.000397	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ALDOB—liver cancer	2.35e-05	0.000397	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	2.33e-05	0.000393	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	2.32e-05	0.000392	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—F2—liver cancer	2.31e-05	0.000391	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTA4—liver cancer	2.31e-05	0.00039	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CD—liver cancer	2.3e-05	0.000388	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HPGDS—liver cancer	2.27e-05	0.000384	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTA2—liver cancer	2.25e-05	0.00038	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CRABP1—liver cancer	2.24e-05	0.000378	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	2.24e-05	0.000378	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CG—liver cancer	2.21e-05	0.000374	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTA1—liver cancer	2.17e-05	0.000366	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.17e-05	0.000366	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.15e-05	0.000363	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—NAT2—liver cancer	2.15e-05	0.000362	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTP1—liver cancer	2.11e-05	0.000357	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PRKCE—liver cancer	2.11e-05	0.000357	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CD—liver cancer	2.09e-05	0.000353	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—HMOX1—liver cancer	2.08e-05	0.000352	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALDOB—liver cancer	2.06e-05	0.000347	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PSMA4—liver cancer	2.03e-05	0.000342	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PSMD10—liver cancer	2.03e-05	0.000342	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.02e-05	0.000341	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	2.01e-05	0.000339	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CB—liver cancer	2e-05	0.000338	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF2—liver cancer	2e-05	0.000338	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.98e-05	0.000334	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GOT2—liver cancer	1.97e-05	0.000333	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CRABP1—liver cancer	1.96e-05	0.000331	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	1.96e-05	0.000331	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HPGDS—liver cancer	1.96e-05	0.000331	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CD—liver cancer	1.95e-05	0.000329	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.95e-05	0.000329	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GSTM1—liver cancer	1.94e-05	0.000328	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—SERPINE1—liver cancer	1.93e-05	0.000325	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.91e-05	0.000323	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CSF2—liver cancer	1.87e-05	0.000315	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—RAF1—liver cancer	1.86e-05	0.000315	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP2E1—liver cancer	1.85e-05	0.000313	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP1A1—liver cancer	1.84e-05	0.000311	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—H2AFX—liver cancer	1.84e-05	0.000311	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—IL2—liver cancer	1.84e-05	0.000311	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CB—liver cancer	1.82e-05	0.000307	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.77e-05	0.000299	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PSMA4—liver cancer	1.74e-05	0.000295	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PSMD10—liver cancer	1.74e-05	0.000295	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—RAF1—liver cancer	1.74e-05	0.000294	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYCS—liver cancer	1.73e-05	0.000293	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—MTHFR—liver cancer	1.72e-05	0.00029	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HPGDS—liver cancer	1.71e-05	0.00029	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GOT1—liver cancer	1.7e-05	0.000287	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GGT1—liver cancer	1.7e-05	0.000287	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GOT2—liver cancer	1.7e-05	0.000287	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CB—liver cancer	1.7e-05	0.000287	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARA—liver cancer	1.68e-05	0.000284	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL2—liver cancer	1.67e-05	0.000282	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TERT—liver cancer	1.66e-05	0.000281	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CPT1B—liver cancer	1.64e-05	0.000277	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GLUL—liver cancer	1.64e-05	0.000277	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	1.64e-05	0.000277	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.61e-05	0.000273	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP2E1—liver cancer	1.6e-05	0.00027	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NR1H4—liver cancer	1.58e-05	0.000267	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IL2—liver cancer	1.56e-05	0.000263	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTA3—liver cancer	1.55e-05	0.000263	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.54e-05	0.000261	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PSMD10—liver cancer	1.53e-05	0.000258	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PSMA4—liver cancer	1.53e-05	0.000258	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTP1—liver cancer	1.53e-05	0.000258	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KDR—liver cancer	1.52e-05	0.000257	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK14—liver cancer	1.51e-05	0.000255	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—HMOX1—liver cancer	1.51e-05	0.000255	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.5e-05	0.000254	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYCS—liver cancer	1.49e-05	0.000252	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GOT2—liver cancer	1.49e-05	0.000251	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ESR1—liver cancer	1.48e-05	0.000251	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—F2—liver cancer	1.47e-05	0.000248	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GOT1—liver cancer	1.46e-05	0.000247	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GGT1—liver cancer	1.46e-05	0.000247	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.46e-05	0.000246	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CG—liver cancer	1.44e-05	0.000244	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTA4—liver cancer	1.42e-05	0.00024	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GSTM1—liver cancer	1.4e-05	0.000237	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APC—liver cancer	1.4e-05	0.000237	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CG—liver cancer	1.4e-05	0.000237	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP2E1—liver cancer	1.4e-05	0.000236	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARG—liver cancer	1.39e-05	0.000235	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTA2—liver cancer	1.39e-05	0.000234	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTA1—liver cancer	1.34e-05	0.000226	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP1A1—liver cancer	1.33e-05	0.000225	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—liver cancer	1.32e-05	0.000224	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—NAT2—liver cancer	1.32e-05	0.000223	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.32e-05	0.000223	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BRAF—liver cancer	1.32e-05	0.000223	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTP1—liver cancer	1.32e-05	0.000222	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYCS—liver cancer	1.31e-05	0.000221	CbGpPWpGaD
Alfentanil—ALB—Metabolism—HMOX1—liver cancer	1.3e-05	0.000219	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GOT1—liver cancer	1.28e-05	0.000217	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GGT1—liver cancer	1.28e-05	0.000217	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CD—liver cancer	1.27e-05	0.000214	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALDOB—liver cancer	1.27e-05	0.000214	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALB—liver cancer	1.25e-05	0.000211	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—MTHFR—liver cancer	1.24e-05	0.00021	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CD—liver cancer	1.23e-05	0.000208	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CA—liver cancer	1.22e-05	0.000206	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SERPINE1—liver cancer	1.22e-05	0.000206	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARA—liver cancer	1.22e-05	0.000206	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TGFB1—liver cancer	1.22e-05	0.000205	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GSTM1—liver cancer	1.21e-05	0.000204	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CRABP1—liver cancer	1.21e-05	0.000204	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—KRAS—liver cancer	1.21e-05	0.000204	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTP1—liver cancer	1.15e-05	0.000195	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP1A1—liver cancer	1.15e-05	0.000194	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HMOX1—liver cancer	1.14e-05	0.000192	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—KRAS—liver cancer	1.13e-05	0.00019	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CA—liver cancer	1.11e-05	0.000187	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CB—liver cancer	1.11e-05	0.000187	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RAF1—liver cancer	1.1e-05	0.000186	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MTOR—liver cancer	1.07e-05	0.000182	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CB—liver cancer	1.07e-05	0.000182	CbGpPWpGaD
Alfentanil—ALB—Metabolism—MTHFR—liver cancer	1.07e-05	0.000181	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GSTM1—liver cancer	1.06e-05	0.000179	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HPGDS—liver cancer	1.06e-05	0.000178	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARA—liver cancer	1.05e-05	0.000177	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CG—liver cancer	1.04e-05	0.000176	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CA—liver cancer	1.03e-05	0.000175	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HRAS—liver cancer	1.03e-05	0.000173	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN1B—liver cancer	1.01e-05	0.00017	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARG—liver cancer	1.01e-05	0.00017	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP1A1—liver cancer	1e-05	0.00017	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TP53—liver cancer	1e-05	0.000169	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AKT1—liver cancer	9.97e-06	0.000168	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CASP3—liver cancer	9.88e-06	0.000167	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL2—liver cancer	9.87e-06	0.000167	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6—liver cancer	9.82e-06	0.000166	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCND1—liver cancer	9.62e-06	0.000162	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—JUN—liver cancer	9.6e-06	0.000162	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—HRAS—liver cancer	9.57e-06	0.000162	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CTNNB1—liver cancer	9.53e-06	0.000161	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.42e-06	0.000159	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PSMA4—liver cancer	9.42e-06	0.000159	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PSMD10—liver cancer	9.42e-06	0.000159	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—MTHFR—liver cancer	9.36e-06	0.000158	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP9—liver cancer	9.34e-06	0.000158	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN1A—liver cancer	9.31e-06	0.000157	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARA—liver cancer	9.19e-06	0.000155	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CD—liver cancer	9.17e-06	0.000155	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GOT2—liver cancer	9.16e-06	0.000155	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK8—liver cancer	9.08e-06	0.000153	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AKT1—liver cancer	9.06e-06	0.000153	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALB—liver cancer	9.05e-06	0.000153	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CG—liver cancer	8.98e-06	0.000152	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARG—liver cancer	8.67e-06	0.000146	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP2E1—liver cancer	8.61e-06	0.000145	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—AKT1—liver cancer	8.45e-06	0.000143	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—liver cancer	8.39e-06	0.000142	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—STAT3—liver cancer	8.3e-06	0.00014	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYCS—liver cancer	8.06e-06	0.000136	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CB—liver cancer	7.99e-06	0.000135	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GGT1—liver cancer	7.91e-06	0.000134	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GOT1—liver cancer	7.91e-06	0.000134	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CD—liver cancer	7.89e-06	0.000133	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CG—liver cancer	7.87e-06	0.000133	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MYC—liver cancer	7.72e-06	0.00013	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TGFB1—liver cancer	7.7e-06	0.00013	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARG—liver cancer	7.59e-06	0.000128	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KRAS—liver cancer	7.13e-06	0.00012	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTP1—liver cancer	7.1e-06	0.00012	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HMOX1—liver cancer	7.01e-06	0.000118	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CD—liver cancer	6.92e-06	0.000117	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CB—liver cancer	6.88e-06	0.000116	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALB—liver cancer	6.83e-06	0.000115	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CA—liver cancer	6.74e-06	0.000114	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CA—liver cancer	6.55e-06	0.000111	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GSTM1—liver cancer	6.53e-06	0.00011	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TP53—liver cancer	6.34e-06	0.000107	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP1A1—liver cancer	6.19e-06	0.000105	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HRAS—liver cancer	6.06e-06	0.000102	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CB—liver cancer	6.03e-06	0.000102	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6—liver cancer	5.8e-06	9.8e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTHFR—liver cancer	5.77e-06	9.75e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARA—liver cancer	5.66e-06	9.56e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AKT1—liver cancer	5.5e-06	9.3e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT1—liver cancer	5.35e-06	9.04e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CA—liver cancer	4.87e-06	8.23e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CG—liver cancer	4.85e-06	8.19e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARG—liver cancer	4.68e-06	7.9e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CD—liver cancer	4.26e-06	7.2e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALB—liver cancer	4.21e-06	7.11e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CA—liver cancer	4.19e-06	7.08e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AKT1—liver cancer	3.98e-06	6.72e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CB—liver cancer	3.71e-06	6.27e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CA—liver cancer	3.67e-06	6.21e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AKT1—liver cancer	3.43e-06	5.79e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKT1—liver cancer	3e-06	5.07e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CA—liver cancer	2.26e-06	3.82e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKT1—liver cancer	1.85e-06	3.12e-05	CbGpPWpGaD
